-
the function of risk factors in neurological disorders. By leveraging human-induced pluripotent stem cell (hiPSC) technology, we will establish hiPSC-derived brain cell models relevant to the study of
-
understanding of tumor heterogeneity, cell plasticity, and the tumor microenvironment in patients with renal cell carcinoma. We apply state-of-the-art sequencing and spatial technologies to explore tumor and
-
partners and across internal work packages. You will report to the Professor Claus Olesen. Your competences You have academic qualifications at PhD level, preferably within Cell Biology, Molecular Biology
-
fibrosis and inflammation. You will also identify potential biomarker gene sets and therapeutic targets, which you will validate in cell and tissue culture models Your job responsibilities As Postdoc in
-
, Cellular Health, Intervention and Nutrition. The department currently hosts 75 full-time scientific staff and 95 PhD students. It also delivers two degree programs: Molecular Biology and Molecular Medicine
-
, Neurobiology, RNA Biology and Innovation, Protein Science, Cellular Health, Intervention and Nutrition. There are currently 75 full-time scientific staff and 95 PhD students. The department is responsible
-
inflammation. The data sources are registry data, cohort phenotypes, single-cell transcriptomics and microbiomes. Expected start date and duration of employment This is a 3–year position from October 1, 2025